Richard E. Middleton

3.5k citations
27 papers · 2.4k · 1 hit paper · h-index 18

Impact in

Papers in

    • Ion channel regulation and function 13
    • Nicotinic Acetylcholine Receptors Study 7
    • Protein Degradation and Inhibitors 4
    • Histone Deacetylase Inhibitors Research 4
    • Ubiquitin and proteasome pathways 3
    • Neuroscience and Neuropharmacology Research 3

Richard E. Middleton

26 papers receiving 2.4k citations

Richard E. Middleton's Hit Papers

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins 2013 · 1.1k citations
1.1k0+4+8Years since publication2505007501000

Peers

Richard E. Middleton
Comparison fields: 5 of 96
  • Sensory Systems 228
  • Hematology 524
  • Molecular Biology 2.0k
  • Cellular and Molecular Neuroscience 386
  • Oncology 374
Replace Donald J. Kyle with:
Donald J. Kyle United States
Stefan Dove Germany
Peter Chase United States
Guy Servant Canada
B. V. L. POTTER United Kingdom
Marian B. Meyers United States
Fabien Vincent United States
Joshua M. Baughman United States
Mario A. Pagano Italy
Adam Zweifach United States
Richard E. Middleton relative to Donald J. Kyle United States Donald J. Kyle's profile →
Citations per field
00.5×4.9×
Donald J. Kyle · 1×
Citations per year

Countries citing papers authored by Richard E. Middleton

Since Specialization
Citations

This map shows the geographic impact of Richard E. Middleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Middleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Middleton more than expected).

Fields of papers citing papers by Richard E. Middleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Middleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Middleton. The network helps show where Richard E. Middleton may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard E. Middleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard E. Middleton Line = papers co-authored together Richard E. Middleton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Hit paper breakdown →
20131108
2 1996216
3 2002196
4 1991173
5 2002108
6 1994105
7 200493
8 199946
9 199846
10 200836
11 201035
12 200933
13 200627
14 201626
15 200625
16 200525
17 200323
18 200820
19 200917
20 200715

About Richard E. Middleton

Richard E. Middleton is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Oncology, Physiology and Organic Chemistry, having authored 27 papers that have together received 2.4k indexed citations. Recurring topics across this work include Ion channel regulation and function (13 papers), Nicotinic Acetylcholine Receptors Study (7 papers), Protein Degradation and Inhibitors (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Pain Mechanisms and Treatments (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Ubiquitin and proteasome pathways (3 papers) and Ion Channels and Receptors (3 papers). The work is most often cited by research in Sensory Systems (228 citations), Hematology (524 citations), Molecular Biology (2.0k citations), Cellular and Molecular Neuroscience (386 citations) and Oncology (374 citations). Richard E. Middleton has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Huahang Sun, James E. Bradner, Constantine S. Mitsiades, Gang Lu, Kwok‐Kin Wong, Christopher J. Ott, William G. Kaelin, Jonathan B. Cohen, Christopher Miller and Ying‐Duo Gao. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Biochemistry, Molecular Pharmacology, Journal of Pharmacology and Experimental Therapeutics and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact